| Factor Information | |
|---|---|
| Data ID | 2750 |
| Factor | diagnostic groups--Mean valve size |
| Description | Diagnosis of PA with VSD was associated with a lower mean age, a smaller mean valve size, and a larger mean valve Z-score . There was no significant difference in follow-up duration among the 3 groups. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | We examined the durability of bioprosthetic valves in the pulmonary position and risk factors associated with bioprosthetic pulmonary valve failure. |
| p Value | 0.001 |
| Conclusion | Diagnosis of PA with VSD was associated with a lower mean age, a smaller mean valve size, and a larger mean valve Z-score . There was no significant difference in follow-up duration among the 3 groups. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 620 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/PA, VSD/DORV/TGA/PS/other |
| Reference | |
|---|---|
| PMID | 21281951 |
| Year | 2011 |
| Title | Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adolescents and young adults | |
| Source | retrospective study | |
| Region | Gyeonggi-do, Korea | |
| Method | searching the database | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PA, VSD/ others(Treatment) | TOF(Control) |
| Number | 181 | N/A |
| Age | 14.2 ± 9.8 years | N/A |
| Gender (Male: Female) | 112:69 | N/A |
| Marker Level | 22.2 ± 2.7 mm/ 22.2 ± 2.4 mm | 23.7 ± 2.5 mm |
